Differential effects of Paclitaxel on dendritic cell function.
John
Justin
J
Oncology, Postgraduate Medical School, Daphne Jackson Road, University of Surrey, Guildford GU2 7WG, UK.
Ismail
Mohammed
M
Riley
Catherine
C
Askham
Jonathan
J
Morgan
Richard
R
Melcher
Alan
A
Pandha
Hardev
H
D019496:Cancer Vaccines; D002454:Cell Differentiation; D049109:Cell Proliferation; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D003131:Combined Modality Therapy; D003713:Dendritic Cells / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D019008:Drug Resistance, Neoplasm; D004705:Endocytosis / Q000187:drug effects; D000949:Histocompatibility Antigens Class II / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D018664:Interleukin-12 / Q000096:biosynthesis / Q000235:genetics; D008213:Lymphocyte Activation / Q000187:drug effects; D008870:Microtubules / Q000378:metabolism; D017239:Paclitaxel / Q000494:pharmacology*; D013601:T-Lymphocytes / Q000378:metabolism / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis / Q000235:genetics
D019496:Cancer Vaccines; D000949:Histocompatibility Antigens Class II; D014409:Tumor Necrosis Factor-alpha; D018664:Interleukin-12; D017239:Paclitaxel